Pursuant to Regulation 29 of SEBI (listing Obligations and Disclosure Requirements) Regulations, 2015, Caplin Point Laboratories has informed that the meeting of the Board of Directors of the Company is scheduled to be held on Friday, November 02, 2018 to consider, approve and take on record the Un-audited Financial Results for quarter/half year ended September 30, 2018. Accordingly, the Trading Window for dealing in the equity shares of the Company will remain closed for Promoters, Directors, other Connected Persons and Employees of the Company from October 09,2018 to November 04,2018 as per the Company's Code of Conduct to regulate, monitor and report trading by insiders adopted by the Board pursuant to SEBl(Prohibition of Insider Trading) Regulations,2015
The above information is a part of company’s filings submitted to BSE.
